St. Jude receives top spot in 2010-11 Best Children's Hospital rankings

NewsGuard 100/100 Score

St. Jude Children's Research Hospital has been named the nation's top children's cancer hospital in the 2010-11 Best Children's Hospital rankings published in U.S. News & World Report. St. Jude received the best overall score summarizing quality of care. St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children and serves as an international resource to physicians and researchers.

"This recognition is an outstanding external acknowledgment for our institution, but more importantly for the dedicated St. Jude faculty and staff who devote their time, talent and lives to the young patients we see every day," said Dr. William E. Evans, St. Jude director and CEO.

This year's rankings were based on how well a hospital did in three areas: reputation; medical outcomes such as cancer survival; and care-related indicators of quality such as the number of patients, nursing staff and other factors.

The 2010-11 Best Children's Hospitals rankings are posted at www.usnews.com/childrenshospitals. They will also be published in the August print issue of U.S. News & World Report.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Measles and rubella vaccine delivered via microarray patch shows promising results